Steroid-induced osteoporosis is the most common cause of secondary osteoporosis and accounts for one-fifth of all osteoporosis cases. The fracture incidence under steroid may be as high as 50%. However, many patients do not undergo appropriate risk assessment and treatment before and after steroid exposure. We described a 56-year-old male patient with multiple punched-out lesions in skull unusually as well as vertebral, fibular, rib and humeral fractures during steroid use without proper management.
INTRODUCTION
Here, in order to emphasize the importance of appropriate prevention and treatment of steroid-induced osteoporosis, we report the very rare case of middle-aged male with multiple fractures in several parts of his body and punched-out lesions in the skull due to long-term steroid use, without other causes of secondary osteoporosis.
CASE REPORT
A 56-year-old Korean male was referred to our hematology department for the evaluation of multiple myeloma.
He had an extensive history of repeated and multiple vertebral fractures. Three years ago, the patient experienced pain in his lower back and on his bilateral hip pain without any particular injury history and was treated with analgesics.
Six months ago, the symptoms progressed and became intolerable in spite of analgesia. Magnetic resonance imaging (MRI) confirmed compression fractures at 9th and 12th thoracic vertebrae and a percutaneous vertebroplasty was performed to help relieve the pain. A month ago, radiographs showed new compression fractures at 8th and 9th thoracic vertebrae and the percutaneous vertebroplasty was performed again (Fig. 1A, 1B. ). Unfortunately, ten days ago, back pain redeveloped and lower extremity weakness T-score = -3.8) (Fig. 3B) . In bone turnover maker, bonespecific alkaline phosphatase (ALP) was raised (36.00 μg/L, reference value: 6.00-30.00) and osteocalcin was decreased The patient was received non-steroid anti-inflammatory analgesic drugs (NSAIDs) in order to relieve pain and 7.5 mg of prednisolone orally to manage adrenal insufficiency.
For the treatment of osteoporosis, vitamin D3 (1,000 IU daily), elementary calcium (500 mg daily) and risedronate (35 mg weakly) were given. Also, he was treated with antituberculosis medication. Unfortunately, six days after his discharge from the hospital, and on his way back home from the first out-patient visit, he had fallen down on his right side and had the proximal humerus fracture. Then, he received conservative treatment (Fig. 2D) . Two months after the medical treatment, osteocalcin decreased (5.27 ng/mL) and serum C-terminal telopeptide (CTx) was lower than the normal value (0.375, reference value < 0.7 ng/mL) and 25(OH) vitamin D3 increased 14.3 ng/mL.
DISCUSSION
In many cases, secondary causes of bone loss are often Bone loss occurs soon after steroid therapy and progresses rapidly within first 3 months and peaks at 6 months, followed by a slower, steady state with continued use. [7] Although both types of bone are affected, the more rapid loss occurs in trabecular bone. Steroids have both direct and indirect effects on the skeletal system. [1, 8, 9] Steroids use. [7] In Korea, there is lack of data on steroid use and steroidinduced osteoporosis and related fractures. Furthermore, general practitioners as well as patients have received less attention. Therefore, here, we report this case with multiple punch-out lesions in the skull after long-term steroid use in order to address the significance of prevention and treatment of steroid-induced osteoporosis
